FucT-XI Activators
FucT-XI activators belong to a chemical class designed to influence the activity of the enzyme fucosyltransferase 11 (FucT-XI), a member of the fucosyltransferase family that catalyzes the transfer of fucose, a hexose sugar, to various glycoproteins and glycolipids. These activators are compounds that increase the enzymatic action of FucT-XI, resulting in enhanced fucosylation processes within biological systems. The FucT-XI enzyme plays a crucial role in the modification of cell surface antigens and can significantly affect the biochemical pathways that rely on carbohydrate recognition and binding. FucT-XI activators may thus influence the structural diversity and function of fucosylated molecules.
The specificity of FucT-XI activators is a critical aspect, as fucosylation is a delicate process within the cell, with broad implications for cell-cell communication and signal transduction. The activators are designed to target the active site or allosteric sites of the FucT-XI enzyme, enhancing its natural function without altering its selectivity for substrate molecules. The resulting modification of fucosylation patterns due to these activators can have various downstream effects on the biological processes where fucosylated structures play a part. It is important to note that these chemical activators may vary in structure, ranging from small, organic molecules to more complex synthetic compounds, each with a unique mechanism of action for increasing the activity of FucT-XI. Research into FucT-XI activators is driven by a deep scientific interest in understanding and manipulating the fucosylation mechanisms inherent in cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese (II) chloride is a cofactor that is essential for the optimal activity of FucT-XI. Manganese ions bind to the active site of FucT-XI and facilitate the proper positioning of the donor substrate for enzymatic action, thereby directly enhancing FucT-XI activity. | ||||||
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $28.00 $35.00 $48.00 $125.00 | 2 | |
Magnesium chloride can serve as a cofactor for many glycosyltransferases, including FucT-XI. It may assist in the stabilization of the enzyme-substrate complex, hence potentially increasing the rate of fucosylation reactions mediated by FucT-XI. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus structure, which can lead to the accumulation of glycosylation enzymes like FucT-XI in the endoplasmic reticulum. This may indirectly enhance FucT-XI activity by increasing local substrate concentrations. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine inhibits mannosidase II activity in the Golgi, which can lead to an accumulation of intermediates that are substrates for FucT-XI. This can indirectly enhance the fucosylation activity of FucT-XI by increasing the availability of these intermediates. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine is an inhibitor of glucosidases, which can lead to an accumulation of glycoproteins with high mannose-type oligosaccharides, potential substrates for FucT-XI. This may indirectly increase FucT-XI activity due to an increased substrate pool. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Deoxynojirimycin inhibits glucosidase I and II, leading to the accumulation of glycoproteins with incomplete glycan structures. These structures can be further modified by FucT-XI, indirectly enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to elevated cAMP, which can influence glycosylation enzyme activity, including FucT-XI. The increase in cAMP may indirectly enhance FucT-XI activity by promoting glycosylation processes in the cell. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which may lead to alterations in glycoprotein folding and availability of substrates for FucT-XI. Although tunicamycin primarily inhibits glycosylation, the resulting stress may induce a compensatory increase in other glycosylation pathways, including those mediated by FucT-XI. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Kifunensine is a mannosidase I inhibitor that results in the accumulation of Man5GlcNAc2-type N-glycans, which are substrates for subsequent modification by FucT-XI. This can lead to an indirect enhancement of FucT-XI activity by providing an increased pool of suitable substrates. | ||||||